Board

 
Dr Jens Sommer-Knudsen

Dr Sommer-Knudsen has more than 20 years of biotechnology related experience gained from industry, academia and government organisations. Dr Sommer-Knudsen has held senior management positions with FMC Bioproducts (now part of Lonza), Gradipore, and IRL, and has extensive experience in developing and producing products and delivering contract services for the biotechnology industry under adherence to strict quality management systems. Dr Sommer Knudsen holds a Ph.D. in Molecular Biology/Biochemistry, a Master of Intellectual Property Law, a Master of Science in Biochemical Engineering and a Bachelor (Hons) of Chemical Engineering. He has been appointed Conjoint Senior Lecturer, Fellow, and Honorary Associate of four university departments in Australia and New Zealand, is an inventor of more than15 patents and patent applications, and has authored of a large number of peer-reviewed papers in international journals.

   
Ard Tijsterman

Mr Tijsterman is a biotechnologist, entrepreneur and business developer with more than 20 years of experience in business and drug development. Started his career as head of biopharmaceutical process development & production at Chiron after which he co-founded Xendo (CMC consulting, drug development & CRO) and stayed on as managing director for 15 years.

In parallel with his Xendo responsibilities Ard has been chairman of the European Committee for Down Stream Processing and board member of the Leiden BioScience Park (70 companies). Mr Tijsterman is currently CEO of Biosana (mAb biosimilars) and on the board of Xendo Holding, Tarpon Biosystems, and IPT.

   
Hamish Hawthorn

Hamish is the CEO of ATP Innovations – Australia leading technology startup incubator. His extensive business networks span all areas of technology, and he has a proven track record in building early-stage businesses. He has led capital raisings and strategic investments for a number of companies and serves on the boards of several portfolio businesses. In late 2008, Hamish co-founded Sydney Angels – a Sydney-based Angel group that invests in early stage high growth companies. Prior to joining ATP Innovations in 2005, Hamish held senior roles in business development and strategy in both the technology and life science sectors.

Hamish holds a Bachelor of Engineering from The University of Sydney, a Master of Business and Technology from the University of New South Wales, and completed the Executive Program for Growing Companies at Stanford University. Hamish is a Visiting Fellow at the University of New South Wales and was the recipient of the Faculty Entrepreneur Award in 2009.